SBIR/STTR Research Award
DNP Polarization Agents for Real-Time Metabolic Imaging and Clinical Diagnosis
Award amount
$225,000Program and phase
STTR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- DYNUPOL, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PA13-089
- Topic code
- NCI
Research abstract
Project Summary / Abstract Although standard MRI techniques provide valuable structural insight, a related technique known as magnetic resonance spectroscopy (MRS) adds powerful real-time metabolic information about the tissues under study. MRS provides early detection of disease, monitoring treatment efficacy, and, in the case of cancer, a dramatic reduction in unnecessary biopsies. However, broad utilization of MRS in the clinic is hindered by the low sensitivity of the underlying nuclear magnetic resonance phenomenon. Dynamic nuclear polarization (DNP) dramatically enhances nuclear magnetic resonance signals by transferring polarization from relatively highly-polarized unpaired-electron spins to nuclear spins (e.g. 1H, 13C, 19F, 23Na, 31P). The unpairedelectrons are supplied by polarizing agents, which are persistent radical species added to a glass-forming matrix. Signal-to-noise ratio (SNR) improvements of over 10,000-fold are achievable with DNP. Hyperpolarized contrast agents and the high sensitivit
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis